The actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin on transforming growth factor-β2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway

Toxicology and Applied Pharmacology

Volumn 137, Issue 1, 1996, Pages 90-99

  Lee, Douglas C ^a,b   Barlow, Keith D ^a   Gaido, Kevin W ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; GENISTEIN; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL STRAIN HEPG2; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL;

2-AMINOPURINE; BINDING, COMPETITIVE; CARCINOMA, HEPATOCELLULAR; DNA FOOTPRINTING; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; TATA BOX; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029866823     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0060     Document Type: Article

References (62)

1. Abbott, B. D., and Birnbaum, L. S. (1990). TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106, 418-432.
2. Abbott, B. D., Harris, M. W., and Birnbaum, L. S. (1992). Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45, 35-53.
3. Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I., and Knowles, B. B. (1979). Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282, 615-616.
4. Apel, I., Yu, C.-L., Wang, T., Dobry, C., Van Antwerp, M. E., Jove, R., and Prochownik, E. V. (1992). Regulation of the junB gene by v-src. Mol. Cell. Biol. 12, 3356-3364.
5. Berghard, A., Gradin, K., Pongratz, I., Whitelaw, M., and Poellinger, L. (1993). Cross-coupling of signal transduction pathways - the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase-c-dependent mechanism. Mol. Cell. Biol. 13, 677-689.
6. Bombick, D. W., and Matsumura, F. (1987). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. J. Biochem. Toxicol. 2, 141-154.
7. Bombick, D. W., Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selective tissues of responsive mice strains. Proc. Natl. Acad. Sci. 85, 4128-4132.
8. Braun, L., Mead, J. E., Panzia, M., Mikumo, R., Bell, G. I., and Fausto, N. (1988). Transforming growth factor beta mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 85, 1539-1543.
9. Buratowski, S. (1994). The basics of basal transcription by RNA polymerase II. Cell 77, 1-3.
10. Carr, F. E., Burnside, J., and Chin, W. W. (1989). Thyroid hormones regulate rat thyrotropin-β gene promoter activity expressed in GH3 cells. Mol. Endocrinol. 3, 709-716.
11. Carrier, F., Owens, R. A., Nebert, D. W., and Puga, A. (1992). Dioxin-dependent activation of murine CYP1A-1 gene transcription requires protein kinase-C-dependent phosphorylation. Mol. Cell. Biol. 12, 1856-1863.
12. Chodosh, L. A. (1994). Mobility shift DNA-binding assay using gel electro-phoresis. In Current Protocols in Molecular Biology (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, Eds.), pp. 12.2.1-12.2.5. Wiley Interscience, Boston.
13. Choi, E. J., Toscano, D. G., Ryan, J. A., Riedel, N., and Toscano, W. A., Jr. (1991). Dioxin induces transforming growth factor-α in human keratinocytes. J. Biol. Chem. 266, 9591-9597.
14. Denison, M. S., Fisher, J. M., and Whitlock, J. P. (1988). Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA 85, 2528-2532.
15. Dignam, J. D., Martin, P. L., Shastry, B. S., and Roeder, R. G. (1983). Eukaryotic gene transcription with purified components. In Methods in Enzymology (R. Wu, L. Grossman, and K. Moldane, Eds.), pp. 582-598. Academic Press, New York.
16. Drapkin, R., and Reinberg, D. (1994). The multifunctional TFIIH complex and transcriptional control. Trends Biol. Sci. 19, 504-508.
17. Enan, E., and Matsumura, F. (1995). Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Biochem. Pharmacol. 49, 249-261.
18. Espel, E., Fromental, C., Reichenbach, P., and Nabholz, M. (1990). Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line. EMBO J. 9, 929-937.
19. Gaido, K. W., and Maness, S. C. (1994). Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 127, 199-208.
20. Gaido, K. W., Maness, S. C., Leonard, L. S., and Greenlee, W. F. (1992). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors α and β2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem. 267, 24591-24595.
21. Galas, D. J., and Schmitz, A. (1978). DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. Nucleic Acids Res. 5, 3157-3170.
22. Goodrich, J. A., and Tijan, R. (1994). TBP-TAF complexes: Selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6, 403-409.
23. Gorman, P., Padmanabhan, R., and Howard, B. H. (1983). High efficiency DNA-mediated transformation of primate cells. Science 221, 551-553.
24. Gradin, K., Whitelaw, M. L., Toftgard, R., Poellinger, L., and Berghard, A. (1994). A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dioxin receptor in human keratinocytes. J. Biol. Chem. 269, 23800-23807.
25. Greenlee, W. F., Skopek, T. R., Gaido, K. W., and Walker, C. (1990). Comparative genetic mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced tumors. In Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons (D. E. Stevenson, J. A. Popp, J. M. Ward, R. M. McClain, T. J. Slaga, and H. C. Pitot, Eds.), pp. 177-186. Liss, New York.
26. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. (1984). Isoquinol-inesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041.
27. Hines, R. N., Mathis, J. M., and Jacob, C. S. (1988). Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis 9, 1599-1605.
28. Huff, J., Lucier, G., and Tritscher, A. (1994). Carcinogenicity of TCDD: Experimental, mechanistic and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol. 34, 343-372.
29. Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P., and Tora, L. (1994). Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79, 107-117.
30. Jaiswal, A. K. (1991). Human NAD(P)H - quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochemistry 30, 10647-10653.
31. Kim, J. L., Nikolov, D. B., and Burley, S. K. (1993a). Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365, 520-527.
32. Kim, Y., Geiger, J. H., Hahn, S., and Sigler, P. B. (1993b). Crystal structure of a yeast TBP/TATA-box complex. Nature 365, 512-520.
33. Kimbrough, R. D. (1987). Human health effects of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs). Annu. Rev. Pharmacol. Toxicol. 27, 87-111.
34. Lee, D. C., Gonzalez, P., and Wistow, G. (1994). Zeta-crystallin: A lens-specific promoter and the gene recruitment of an enzyme as a crystallin. J. Mol. Biol. 236, 669-678.
35. Lok, S., Stevens, W., Breitman, M. L., and Tsui, L.-C. (1989). Multiple regulatory elements of the murine γ2-crystallin promoter. Nucleic Acids Res. 17, 3563-3582.
36. Ma, X. F., Mufti, N. A., and Babish, J. G. (1992). Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachloro-p-dioxin exposure in vivo and in vitro. Biochem. Biophys. Res. Commun. 189, 59-65.
37. Malipiero, U., Holler, M., Werner, M., and Fontana, A. (1990). Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-β2 gene reveals striking differences to the TGF-β1 and -β3 genes. Biochem. Biophys. Res. Commun. 171, 1145-1151.
38. Manley, J. L. (1984). Transcription of eukaryotic genes in a whole cell extract. In Transcription and Translation: A Practical Approach (B. D. Hames and S. J. Higgins, Eds.), pp. 71-88. IRL Press, Oxford.
39. Maxam, A. M., and Gilbert, W. (1977). A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74, 560-564.
40. Noma, T., Glick, A. G., Geiser, A. G., O'Reilly, M. A., Miller, J., Roberts, A. B., and Sporn, M. B. (1991). Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors, 4, 247-255.
41. Okino, S. T., Pendurthi, U. R., and Tukey, R. H. (1992). Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cypla-1 and Cypla-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem, 267, 6991-6998.
42. O'Reilly, M. A., Geiser, A. G., Kim, S. J., Bruggeman, L. A., Luu, A. X., Roberts, A. B., and Sporn, M. B. (1992). Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta2 promoter. J. Biol. Chem. 267, 19938-19943.
43. Pitot, H. C., Goldsworthy, T., Campbell, H. A., and Poland, A. (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatogenesis from diethylnitrosamine. Cancer Res. 40, 3616-3620.
44. Poland, A., Glover, E., and Bradfield, C. A. (1991). Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten. Mol. Pharmacol. 39, 20-26.
45. Pongratz, I., Stromstedt, P.-E., Mason, G. G. F., and Poellinger, L. (1991). Inhibition of specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266, 16813-16817.
46. Quattrochi, L. C., Tien, V., and Tukey, R. (1994). The human CYP1A2 gene and induction by 3-methylcholanthrene. J. Biol. Chem. 269, 6949-6954.
47. Rambaldi, A., Bettoni, S., Rossi, V., Tini, M. L., Giudici, G., Rizzo, V., Bassan, R., Mantovani, A., Barbui, T., and Biondi, A. (1993). Transcriptional and post-transcriptional regulation of IL-1beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia. Br. J. Haematol. 83, 204-211.
48. Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C., and Daniel, C. W. (1991). Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 113, 867-878.
49. Ron, D., Brasier, A. R., Wright, K. A., Tate, J. E., and Habener, J. F. (1990). An inducible 50-kilodalton NFkB-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol. Cell. Biol. 10, 1023-1032.
50. Russell, W. E., Coffey, R. J., Ouellette, A. J., and Moses, H. L. (1988). Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85, 5126-5130.
51. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
52. Schecter, A., Furst, P., Furst, C., Papke, O., Ball, M., Ryan, J. J., Cau, H. D., Dai, L. C., Quynh, H. T., Coung, H. Q., Phuong, N. T. N., Phiet, P. H., Beim, A., Constable, J., Startin, J., Samedy, M., and Seng, Y. K. (1994). Chlorinated dioxins and dibenzofurans in human tissue from general populations: a selective review. Environ. Health Perspect. 102, 159-171.
53. Scholer, H. R., Hatzopoulos, A. K., Balling, R., Suzuki, N., and Grus, P. (1989). EMBO J. 8, 2543-2550.
54. Sporn, M. B., Roberts, A. B., Wakefield, L. M., and Assoian, R. K. (1986). Transforming growth factor-β: biological function and chemical structure. Science 233, 532-534.
55. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F. (1991). Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1β. Science 254, 415-418.
56. Tijan, R., and Maniatis, T. (1994). Transcriptional activation: A complex puzzle with few easy pieces. Cell 77, 5-8.
57. Tschirley, F. H. (1986). Dioxin. Sci. Am. 254, 29-35.
58. Wight, P. A., Crew, M. D., and Spindler, S. R. (1988). Sequences essential for activity of the thyroid hormone responsive transcription stimulating element of the rat growth hormone gene. Mol. Endocrinol. 2, 536-542.
59. Willes, R. F., Nestmann, E. R., Miller, P. A., Orr, J. C., and Munro, I. C. (1993). Scientific principles for evaluating the potential for adverse effects from chlorinated organic chemicals in the environment. Regul. Toxicol. Pharmacol. 18, 313-356.
60. Wilson, D. R., Juan, T. S.-C., Wilde, M. D., Fey, G. H., and Darlington, G. J. (1990). A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol. Cell. Biol. 10, 6181-6191.
61. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
62. Yao, E. F., and Denison, M. S. (1992). DNA sequence determinants for binding of transformed Ah-receptor to a dioxin-responsive enhancer. Biochemistry 31, 5060-5067.